OR MPJE cheat sheet

Oregon Board of Pharmacy (OAR Chapter 855) licenses pharmacies, pharmacists, certified pharmacy technicians, and pharmacy interns; registration renewal cycles and CE requirements are set by rule, not statute alone.

Oregon requires pharmacists to complete continuing education including specified hours in pharmacy law and patient safety topics; CE must be reported to the Board through its approved tracking system at renewal.

Oregon's drug outlet registration and pharmacist-in-charge (PIC) responsibilities: the PIC must ensure compliance with recordkeeping, security, and personnel supervision rules, and the Board must be notified of PIC changes.

Oregon prescription requirements: prescriptions must include prescriber name, drug name/strength/quantity, directions, date, and patient name; electronic prescriptions are the default, with limited exceptions for oral/paper orders.

Oregon pharmacist dispensing authority includes collaborative drug therapy management (CDTM) agreements and authority to dispense emergency contraception and certain self-administered hormonal contraceptives under statewide protocol.

Oregon's Prescription Drug Monitoring Program (PDMP) requires pharmacists to check the PDMP before dispensing opioids and other scheduled drugs under specified circumstances, with documented exceptions.

Oregon allows pharmacy technicians to perform certain duties under pharmacist supervision; technician ratio and certification requirements are set by Board rule, and interns must be enrolled in an approved program.

Oregon requires reporting of drug losses, thefts, and significant adverse events to the Board within specified timeframes; pharmacies must maintain records for the period required by rule (generally at least two years).

Oregon's immunization authority: pharmacists and certified technicians may administer vaccines to specified age groups under protocol, with documentation and reporting requirements to the state immunization registry.

DEA registration: practitioners must register with DEA for each principal place of business; registration is separate from state licensure, and a state license is a prerequisite in most cases.

Controlled substance schedules (CSA): Schedule II has high abuse potential and no accepted medical use for some drugs; Schedule III-V have decreasing abuse potential, and all require a valid DEA registration to handle.

Schedule II prescriptions: no refills permitted; a prescription must be written/transmitted with specific requirements, and emergency oral orders must be followed by a written prescription within 7 days.

Schedule III-V prescriptions: may be refilled up to 5 times within 6 months of the date written unless the prescriber specifies otherwise; partial fills are permitted under DEA rules with conditions.

The Poison Prevention Packaging Act (PPPA) requires child-resistant packaging for most oral prescription drugs, with exceptions for certain drugs and patient-requested non-child-resistant packaging.

HIPAA privacy and security rules govern protected health information; pharmacies must have safeguards, business associate agreements, and breach notification procedures.

FDA drug approval and labeling: prescription drugs require an approved NDA/ANDA, and pharmacists must follow REMS requirements, including restricted distribution and patient counseling for certain drugs.

The Combat Methamphetamine Epidemic Act (CMEA) requires pharmacies to log sales of ephedrine/pseudoephedrine products, verify purchaser identity, and enforce daily/monthly purchase limits.

Federal recordkeeping: controlled substance records must be maintained for at least 2 years and be readily retrievable; biennial inventories are required for registrants.